What is the appropriate management for a 72-year-old woman presenting with new headache and jaw pain?

Immediate Glucocorticoid Therapy for Suspected Giant Cell Arteritis

A 72-year-old woman with new-onset headache and jaw pain requires immediate high-dose glucocorticoid therapy while urgently pursuing diagnostic confirmation of giant cell arteritis (GCA), as delay in treatment risks permanent vision loss.

Clinical Reasoning

The combination of new headache and jaw pain in a 72-year-old woman is pathognomonic for giant cell arteritis until proven otherwise. Jaw claudication (pain with chewing) is one of the most specific symptoms for GCA 1. This presentation demands immediate action because:

• Vision loss is the catastrophic complication - once it occurs, it is typically irreversible
• GCA is the most common vasculitis in patients over 50 years of age, particularly in those of Northern European descent 1
• The probability of secondary headache increases dramatically with age, making GCA a critical consideration 2, 3

Immediate Management Algorithm

Step 1: Start Glucocorticoids Immediately (Same Day)

• Do not wait for diagnostic confirmation to initiate treatment
• Begin prednisone 40-60 mg daily (or equivalent) 1
• Glucocorticoids remain the mainstay treatment for GCA 1
• Treatment should begin before temporal artery biopsy, as histologic changes persist for weeks after initiation

Step 2: Urgent Diagnostic Workup (Within 24-48 Hours)

• ESR and CRP - typically markedly elevated in GCA
• Temporal artery biopsy - remains gold standard for cranial GCA diagnosis 1
• Vascular imaging (temporal artery ultrasound, MRA, or CTA) - increasingly used to identify large vessel involvement 1
• The 2021 ACR/Vasculitis Foundation guideline specifically supports imaging to identify large vessel involvement 1

Step 3: Assess for Vision-Threatening Features

Look specifically for:

• Visual symptoms (blurred vision, diplopia, amaurosis fugax)
• Scalp tenderness
• Temporal artery abnormalities (tenderness, decreased pulse, nodularity)
• Constitutional symptoms (fever, weight loss, malaise)

If any visual symptoms are present, this constitutes a medical emergency requiring same-day ophthalmology consultation and consideration for IV methylprednisolone (500-1000 mg daily for 3 days).

Additional Considerations

Glucocorticoid-Sparing Agents

The 2021 guideline supports the use of glucocorticoid-sparing immunosuppressive agents in GCA 1. Tocilizumab is FDA-approved for GCA and should be considered early, particularly given the significant morbidity associated with prolonged high-dose glucocorticoid therapy in elderly patients 1.

Common Pitfalls to Avoid

• Never delay glucocorticoids while awaiting biopsy or imaging - the risk of permanent vision loss outweighs any diagnostic uncertainty
• Don't dismiss the diagnosis if ESR/CRP are normal - approximately 10-15% of GCA patients have normal inflammatory markers
• Don't assume it's a benign primary headache disorder simply because the patient is elderly - while primary headaches comprise two-thirds of headaches in the elderly 3, the consequences of missing GCA are catastrophic

Alternative Diagnoses to Consider (After Securing GCA Workup)

If GCA is ruled out, consider:

• Temporomandibular joint disorder
• Trigeminal neuralgia
• Dental pathology
• Tension-type headache or migraine (though new-onset migraine after age 50 is uncommon)
• Other secondary causes: intracranial lesions, medication overuse 2, 3

The key principle: In a 72-year-old with new headache and jaw pain, treat first for GCA, then investigate. The cost of missing this diagnosis is permanent blindness.